News
Stay at the forefront of drug delivery innovation in the contract development and manufacturing organization (CDMO) space. Explore our latest news and announcements, where the demands of today meet the possibilities of tomorrow.
Company announcement
Kindeva awarded up to $226 million contract to supply ATNAA autoinjectors to the Defense Logistics Agency
News filter
Viatris Inc. announces receipt of the first FDA approval for generic version of Symbicort® inhalation aerosol, Breyna™ (Budesonide and Formoterol Fumarate Dihydrate inhalation aerosol), in partnership with Kindeva
PITTSBURGH and ST. PAUL, Minn., March 16, 2022 — Viatris Inc. (NASDAQ: VTRS) and Kindeva Drug Delivery L.P. today announced that, Mylan Pharmaceuticals Inc., a Viatris subsidiary, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for BreynaTM (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), the first approved generic version of AstraZeneca’s Symbicort®. Breyna, […]
Read more
Kindeva Drug Delivery to manufacture new, greener inhalers at UK manufacturing site to help cut carbon emissions
February 16, 2022 – One of the UK’s biggest asthma inhaler manufacturers has today announced its intention to invest in its UK manufacturing site to support the development of a new generation of greener inhalers, designed to help support the National Health Service (NHS) to cut a contributor to its emissions. The new inhalers will […]
Read moreLet’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.